Junction Bioscience
YC W24New York City, US · Founded 2024 · 2 employees on LinkedIn · 1 known investors
Junction Bioscience develops AI-driven software that generates and tests scientific hypotheses to discover new drug candidates, with an initial focus on therapies targeting neuroinflammatory and immunological diseases.
Founders & leadership· Y Combinator alumni (W24)
Junction Bioscience was founded in 2024 by Brian Petkov.
BP
Brian PetkovinFounder · Chief Executive OfficerBrian Petkov holds degrees in mathematics and chemistry from Duke University and completed doctoral training at NYU. He previously served as Vice President at a computational drug design startup, where he led machine learning operations and oversaw team expansion in drug discovery efforts.
Investors · 1
In the news
Frequently asked questions
- What does Junction Bioscience do?
- Junction Bioscience develops AI-driven software that generates and tests scientific hypotheses to discover new drug candidates, with an initial focus on therapies targeting neuroinflammatory and immunological diseases.
- Who founded Junction Bioscience?
- Junction Bioscience was founded by Brian Petkov in 2024.
- Who are Junction Bioscience's investors?
- Junction Bioscience's investors include Y Combinator.
- Where is Junction Bioscience headquartered?
- Junction Bioscience is headquartered in New York City, US.